肾性甲状旁腺功能亢进症行甲状旁腺次全切除术的结局
单机构回顾性队列研究纳入1990—2022年因肾性甲状旁腺功能亢进症接受初次甲状旁腺次全切除术的204例透析患者,139例有随访数据。以75-100 mg为目标残留组织量时,复发14/139(10%),中位复发间隔58.6个月;复发者术后即刻甲状旁腺激素降至<250 pg/mL的比例为40%(4/10),非复发者为65%(80/123),差异未达统计学显著(P = .11);19例 later 接受肾移植者无复发(P = .2)。
要点
- 以75-100 mg为目标残留量行甲状旁腺次全切除术,复发率为10%(14/139)。
- 复发中位间隔为58.6个月(范围8-180个月)。
- 术后接受肾移植的19例患者无复发(P = .2)。
核心结论
- 肾性甲状旁腺功能亢进症行甲状旁腺次全切除术时,采用75-100 mg目标残留量可带来较低的并发症发生率。
- 肾移植后持久治愈的可能性似乎更高。
研究设计与样本
- 单机构回顾性队列研究,纳入1990—2022年因肾性甲状旁腺功能亢进症在透析状态下接受初次甲状旁腺次全切除术的患者。
- 甲状旁腺次全切除术定义为切除3枚甲状旁腺±部分切除第4枚甲状旁腺,残留组织约75-100 mg,切除后术中甲状旁腺激素目标为150-250 pg/mL。
- 204例符合纳入标准,其中139例(68%)有随访数据;58%(80/139)为女性,中位年龄45岁。
主要发现
- 手术并发症包括2例血肿(1.4%)、1例喉返神经损伤(<1%),无患者因静脉补钙而需要再入院。
- 采用75-100 mg目标残留量时,复发性肾性甲状旁腺功能亢进症不常见(14/139,10%),中位复发间隔为58.6个月(范围8-180个月)。
- 复发者术后即刻甲状旁腺激素降至<250 pg/mL的比例为40%(4/10),非复发者为65%(80/123),差异未达统计学显著(P = .11)。
- 复发者术后即刻甲状旁腺激素中位下降幅度为70%,非复发者为81%,差异未达统计学显著(P = .8)。
- 19例 later 接受肾移植的患者中无复发(P = .2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Renal hyperparathyroidism due to end-stage kidney disease is associated with considerable morbidity, and when refractory is treated with parathyroidectomy. Recurrent renal hyperparathyroidism is a major surgical complication, yet initial target parathyroid remnant size and outcomes, including rates of recurrence are not well elucidated. METHODS: This is a single-institution retrospective cohort study of patients who underwent initial subtotal parathyroidectomy for renal hyperparathyroidism on dialysis, from 1990-2022. The subtotal parathyroidectomy was defined as resection of 3 parathyroid glands ± partial resection of the fourth gland leaving a remnant of ∼75-100 mg, and postresection intraoperative parathyroid hormone goal was 150-250 pg/mL. Clinical data were examined for outcomes. RESULTS: Among 204 patients who met inclusion criteria, 139 (68%) had follow-up data; 58% (80/139) were women and median age was 45 years. Surgical complications included 2 hematomas (1.4%), 1 recurrent laryngeal nerve injury (<1%), and no patient required readmission for intravenous calcium. Using a target remnant size of 75-100 mg, recurrent renal hyperparathyroidism was uncommon (14/139, 10%) and arose at a median interval of 58.6 months (range, 8-180). In cases of recurrence, the postresection intraoperative parathyroid hormone level was less likely to drop <250 pg/mL (40%, 4/10 vs nonrecurrence 65%, 80/123; P = .11) with a slightly lower median decrease (70% vs 81% in nonrecurrence, P = .8); however, neither were significant. Recurrence did not occur in the 19 patients who later received kidney transplantation (P = .2). CONCLUSION: In subtotal parathyroidectomy for renal hyperparathyroidism, use of a target 75-100 mg remnant size results in low complication rates. Durable cure appears to be more likely with renal transplantation.
引用
- Baugh KA, Yip L, Ramonell KM, et al. Outcomes of subtotal parathyroidectomy for renal hyperparathyroidism. Surgery. 2023. PMID: 37945480. doi:10.1016/j.surg.2023.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。